Abiopharma

New Form 8-K/A - InspireMD, Inc. Filed: 2025-09-08 AccNo: 0001493152-25-012805 Size: 208 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 8-K - Adaptimmune Therapeutics PLC Filed: 2025-09-08 AccNo: 0001558370-25-011925 Size: 321 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang

Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)

Coherent’s Chief Technology Officer Named Recipient of the Prestigious 2025 Dr. Lisa Su Woman of Innovation Award

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

New Form 6-K - Nyxoah SA Filed: 2025-09-08 AccNo: 0001104659-25-088240 Size: 39 KB

Kerr Douglas 🔴 sold 4.4K shares of Dyne Therapeutics, Inc. (DYN) at $13.41 Transaction Date: Sep 04, 2025 | Filing ID: 113538

New Form 8-K - BICYCLE THERAPEUTICS PLC Filed: 2025-09-08 AccNo: 0001104659-25-088238 Size: 262 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

MindMed Announces New Employee Inducement Grants

New Form 144 - CORE MOLDING TECHNOLOGIES INC Filed: 2025-09-08 AccNo: 0001949846-25-000454 Size: 5 KB

New Form 6-K - SciSparc Ltd. Filed: 2025-09-08 AccNo: 0001213900-25-085510 Size: 11 KB

Ionis to host investors and analysts for Innovation Day 2025

Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering

Abivax Presents First Half 2025 Financial Results